BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8396525)

  • 1. Could natural inhibitors of tumor necrosis factor-alpha modify the clinical course of fulminant meningococcemia?
    Villard J; Roux-Lombard P; Hugli A; Dayer JM
    Crit Care Med; 1993 Sep; 21(9):1396-400. PubMed ID: 8396525
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts.
    Bjerre A; Ovstebø R; Kierulf P; Halvorsen S; Brandtzaeg P
    Clin Infect Dis; 2000 Apr; 30(4):643-7. PubMed ID: 10770723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin therapy in acute meningococcemia.
    Hathaway WE
    J Pediatr; 1973 May; 82(5):900-1. PubMed ID: 4698969
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral antibiotics and outcome in meningococcemia.
    Radetsky M
    Arch Intern Med; 2000 Jul; 160(14):2220-3. PubMed ID: 10904473
    [No Abstract]   [Full Text] [Related]  

  • 5. Timing therapy for meningococcal infection.
    Radetsky M
    Pediatr Infect Dis J; 1997 May; 16(5):540-2. PubMed ID: 9154565
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease.
    Halstensen A; Ceska M; Brandtzaeg P; Redl H; Naess A; Waage A
    J Infect Dis; 1993 Feb; 167(2):471-5. PubMed ID: 8421185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 50 Years Ago in TheJournal ofPediatrics: Heparin Therapy in Fulminant Meningococcemia.
    Dorn E; Toltzis P
    J Pediatr; 2019 Sep; 212():207. PubMed ID: 31439162
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
    Zenz W; Muntean W; Zobel G; Grubbauer HM; Gallistl S
    Thromb Haemost; 1995 Aug; 74(2):802-3. PubMed ID: 8585030
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values.
    Froon AH; Bemelmans MH; Greve JW; van der Linden CJ; Buurman WA
    Crit Care Med; 1994 May; 22(5):803-9. PubMed ID: 8181289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 levels in febrile, young children with and without occult bacteremia.
    Strait RT; Kelly KJ; Kurup VP
    Pediatrics; 1999 Dec; 104(6):1321-6. PubMed ID: 10585983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia, hormones and cytokines in fatal meningococcal septicemia.
    Romijn JA; Godfried MH; Wortel C; Sauerwein HP
    J Endocrinol Invest; 1990 Oct; 13(9):743-7. PubMed ID: 2292658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of meningococcal disease].
    Gelli GP
    Minerva Pediatr; 1978 Dec; 30(24):1991-8. PubMed ID: 753965
    [No Abstract]   [Full Text] [Related]  

  • 13. Endotoxin release and cytokine production in acute and chronic meningococcaemia.
    Prins JM; Lauw FN; Derkx BH; Speelman P; Kuijper EJ; Dankert J; van Deventer SJ
    Clin Exp Immunol; 1998 Nov; 114(2):215-9. PubMed ID: 9822279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease--some issues in treatment.
    Wall RA
    J Infect; 2001 Feb; 42(2):87-99. PubMed ID: 11531314
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of meningococcal infection by QPCR: detection and quantification of DNA / Neisseria meningitidis.
    Nemescu RE; Ursu RG; Dorobăţ CM; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):888-92. PubMed ID: 23272547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating fibrin in meningococcemia.
    Kisker CT; Rush R
    J Pediatr; 1973 May; 82(5):787-91. PubMed ID: 4698951
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia.
    Waring PM; Waring LJ; Metcalf D
    J Infect Dis; 1994 Nov; 170(5):1224-8. PubMed ID: 7963717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
    Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
    J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic meningococcemia: a report of 26 cases and literature review.
    Lefèvre B; Poinsignon Y; Piau C; Javaugue FC; Talarmin JP; Lefebvre M; Varache N; Drouin H; Tattevin P;
    Infection; 2019 Apr; 47(2):285-288. PubMed ID: 30341638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity.
    Moscovitz H; Shofer F; Mignott H; Behrman A; Kilpatrick L
    Crit Care Med; 1994 Jul; 22(7):1102-7. PubMed ID: 8026198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.